Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Nat Protoc. 2021 Jun 28;16(8):3874–3900. doi: 10.1038/s41596-021-00562-w

Table 3.

Colon organoid growth medium composition

Component Stock concentration Volume added Final concentration Recommended storage condition

WRN-conditioned media 100 × 6.5 ml 65 × −20 °C freezer
Base media 100 × 3.2 ml* 32 × 4 °C fridge
B27 50 × 200 μl 1 × −20 °C freezer
Nicotinamide 1 M 100 μl 10 mM −20 °C freezer
N2 100 × 100 μl 1 × −20 °C freezer
N-acetyl cysteine 500 mM 10 μl 500 μM −20 °C freezer
A 83-01 500 μM 10 μl 500 nM −20 °C freezer
Y-27632 dihydrochloride 10 mM 10 μl 10 μM −20 °C freezer
SB 202190 30 mM 3.33 μl 10 μM −20 °C freezer
EGF 250 μg/ml 2 μl 50 ng/ml −20 °C freezer
human [Leu15]-Gastrin 100 μM 1 μl 10 nM −20 °C freezer
Prostaglandin E2 10 mM 2 μl** 5 nM −80 °C freezer
Final volume 10.14 ml
*

Base media consists of Advanced DMEM/F12, 2 mM Glutamax, 10 mM HEPES, 100 units/ml penicillin/streptomycin, described in Table 2. WRN: Wnt, R-spondin 1, Noggin. EGF: epidermal growth factor.

**

Prostaglandin E2 should be diluted before adding. Make a dilution of 1 μl PGE stock to 349 μl BM. Add 2 μl PGE dilution for 10 ml media.